Obesity and the risk of cholangiocarcinoma: A meta-analysis

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6831-6838

  Li, Jun Shan ^a   Han, Tian Jie ^a   Jing, Nie ^a   Li, Lei ^b   Zhang, Xiao Hua ^a   Ma, Feng Zhen ^a   Liu, Ji Yong ^a  

^a SHANDONG UNIVERSITY   (China)

^b Tai'an Central Hospital   (China)

Author keywords

Case control study; Cholangiocarcinoma; Cohort study; Meta analysis; Obesity; Overweight

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; BODY MASS; BODY WEIGHT; CANCER RISK; DISEASE ASSOCIATION; ETHNICITY; HUMAN; INCIDENCE; OBESITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; HUMANS; OBESITY; OVERWEIGHT; RISK FACTORS;

EID: 84905009299     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1939-4     Document Type: Article

References (40)

1. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006;3:33-42.
2. Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates for intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut. 2001;48:816-20. (Pubitemid 32479209)
3. Khan SA, Emadossadaty S, Ladep N, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56:848-54.
4. Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol. 2007;13:1505-15. (Pubitemid 46672657)
5. Claessen MM, Vleggaar FP, Tytgat KM, et al. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50:158-64.
6. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology. 2011;54:173-84.
7. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors and pathogenesis of cholangiocarcinoma. HPB. 2008;10:77-82. (Pubitemid 351934989)
8. Adenugba A, Khan SA, Taylor-Robinson SD, et al. Polychlorinated biphenyls in bile of patients with biliary tract cancer. Chemosphere. 2009;76:841-6.
9. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15:556-65.
10. Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer-a dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23:1665-71.
11. Stroup DF, Berlin JA, Morton SC, Thacker SB, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology Group. JAMA. 2000;283:2008-12. (Pubitemid 30214957)
12. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of non randomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.
13. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.
14. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-29.
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. (Pubitemid 17189972)
17. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629-34. (Pubitemid 27387172)
18. Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Cause Control. 2001;12:13-21. (Pubitemid 32125897)
19. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni Jr JF. Obesity and cancer risk among white and black United States veterans. Cancer Cause Control. 2004;15:35-43. (Pubitemid 38339970)
20. Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol. 2005;23:4742-54. (Pubitemid 46224078)
21. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni Jr JF. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Cause Control. 2006;17:901-9. (Pubitemid 44078281)
22. Ishiguro S, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification. Cancer Cause Control. 2008;19:33-41.
23. Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5:1221-8. (Pubitemid 47496233)
24. Welzel TM, Mellemkjaer L, Gloria G, et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer. 2007;120:638-41. (Pubitemid 46001359)
25. Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Brit J Cancer. 2009;100:178-80.
26. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011;54:463-71.
27. Chaiteerakij R, Yang JD, Harmsen WS, et al. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology. 2013;57:648-55.
28. Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296:193-201. (Pubitemid 44050373)
29. Dal Maso L, La Vecchia C, Franceschi S, et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Cause Control. 2000;11:137-44. (Pubitemid 30088392)
30. Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev. 2010;11:19.
31. Somasundar P, Yu AK, Vona-Davis L, McFadden W. Differential effects of leptin on caner in vitro. J Surg Res. 2003;113:50-5. (Pubitemid 36999792)
32. Cannata D, Fierz Y, Vijayakumar A, LeRoith D. Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med. 2010;77:197-213.
33. La Vecchia C. Hypothesis: is the fall in Helicobacter pylori related to the global rise in body mass index? Eur J Cancer Prev. 2011;20:556.
34. Clayton PE, Banerjee I, Murray PG, et al. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol. 2011;7:11-24.
35. Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346-53. (Pubitemid 38529873)
36. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab: TEM. 2006;17:328-36. (Pubitemid 44397568)
37. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008;114:71-83. (Pubitemid 351998746)
38. Vansaun MN. Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res. 2013;19:1926-32.
39. Xue RQ, Gu JC, Du ST, et al. Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7 cells in a nude mouse xenograft model. Chin Med J. 2012;125:1563-70.
40. Yang SN, Chen HT, Tsou HK, et al. Leptin enhances cellmigration in human chondrosarcoma cells through OBRl leptin receptor. Carcinogenesis. 2009;30:566-74.